Related Experiment Video
Updated: Jun 9, 2025

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
The Hidden Heart: Exploring Cardiac Damage Post-Stroke: A Narrative Review
Marian Mitrică1, Lorenzo Lorusso2, Alexandru-Andrei Badea3
1Clinical Neurosciences Department, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Insights
Stroke-heart syndrome (SHS) involves cardiac issues after ischemic stroke. Early detection and management of these brain-heart complications are crucial for improving stroke survivor outcomes.
Area of Science:
- Cardiology
- Neurology
- Internal Medicine
Background:
- Stroke-heart syndrome (SHS) comprises cardiac complications following ischemic stroke.
- The brain-heart axis plays a critical role in SHS pathophysiology.
Purpose of the Study:
- To review the pathophysiology, clinical manifestations, and implications of SHS.
- To highlight the absence of specific management guidelines for SHS.
Main Methods:
- Comprehensive literature search and synthesis of recent studies.
- Exploration of mechanisms underlying SHS and identification of knowledge gaps.
Main Results:
- Five cardinal manifestations of SHS: elevated cardiac troponin, myocardial infarction, left ventricular dysfunction, arrhythmias, and sudden cardiac death.
- Acute ischemic stroke triggers autonomic dysfunction, leading to myocardial injury.
Conclusions:
- Early detection and multidisciplinary management of cardiac complications post-stroke are essential.
- Further research is needed to establish evidence-based protocols for SHS to improve patient outcomes and reduce mortality.
Abstract:
Stroke-heart syndrome (SHS), a critical yet underrecognized condition, encompasses a range of cardiac complications that arise following an ischemic stroke. This narrative review explores the pathophysiology, clinical manifestations, and implications of SHS, focusing on the complex interplay between the brain and the heart. Acute ischemic stroke (AIS) triggers autonomic dysfunction, leading to a surge in catecholamines and subsequent myocardial injury. Our review highlights the five cardinal manifestations of SHS: elevated cardiac troponin (cTn) levels, acute myocardial infarction, left ventricular dysfunction, arrhythmias, and sudden cardiac death. Despite the significant impact of these complications on patient outcomes, there is a notable absence of specific guidelines for their management. Through a comprehensive literature search, we synthesized findings from recent studies to elucidate the mechanisms underlying SHS and identified gaps in the current understanding. Our findings underscore the importance of early detection and multidisciplinary management of cardiac complications post-stroke. Future research should focus on establishing evidence-based protocols to improve clinical outcomes for stroke patients with SHS. Addressing this unmet need will enhance the care of stroke survivors and reduce mortality rates associated with cardiac complications.

